TTP-RA | Interleukin Related interleukin-related.com

Product Name :
TTP-RA

Search keywords :
RAGE

drugId :
null

Target Vo:
Advanced glycosylation end product-specific receptor

Target Vo Short Name :
AGER

Moa_Name:
Advanced glycosylation end product-specific receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vtv Therapeutics Llc

Active Company_Name :
Vtv Therapeutics Llc

Active Indication_Name:
Diabetes Mellitus, Type 1

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bimagrumab TGF-beta/Smad
Cosibelimab manufacturer
Cdk7 Antibody: Cdk7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Cdk7. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts